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Abstract
Background: Circadian rhythms are endogenous, self-sustained oscillations with approximately
24-hr rhythmicity that are manifested in various physiological and metabolic processes. The
circadian organization of these processes in mammals is governed by the master oscillator within
the suprachiasmatic nuclei (SCN) of the hypothalamus. Recent findings revealed that circadian
oscillators exist in most organs, tissues, and even in immortalized cells, and that the oscillators in
peripheral tissues are likely to be coordinated by SCN, the master oscillator. Some candidates for
endogenous entrainment factors have sporadically been reported, however, their details remain
mainly obscure.
Results:  We developed the in vitro real-time oscillation monitoring system (IV-ROMS) by
measuring the activity of luciferase coupled to the oscillatory gene promoter using photomultiplier
tubes and applied this system to screen and identify factors able to influence circadian rhythmicity.
Using this IV-ROMS as the primary screening of entrainment factors for circadian clocks, we
identified 12 candidates as the potential entrainment factor in a total of 299 peptides and bioactive
lipids. Among them, four candidates (endothelin-1, all-trans retinoic acid, 9-cis retinoic acid, and
13-cis retinoic acid) have already been reported as the entrainment factors in vivo and in vitro. We
demonstrated that one of the novel candidates, 15-deoxy-∆12,14-prostaglandin J2 (15d-PGJ2), a
natural ligand of the peroxisome proliferator-activated receptor-γ (PPAR-γ), triggers the rhythmic
expression of endogenous clock genes in NIH3T3 cells. Furthermore, we showed that 15d-PGJ2
transiently induces Cry1,  Cry2, and Rorα  mRNA expressions and that 15d-PGJ2-induced
entrainment signaling pathway is PPAR-γ – and MAPKs (ERK, JNK, p38MAPK)-independent.
Conclusion: Here, we identified 15d-PGJ2 as an entrainment factor in vitro. Using our developed
IV-ROMS to screen 299 compounds, we found eight novel and four known molecules to be
potential entrainment factors for circadian clocks, indicating that this assay system is a powerful and
useful tool in initial screenings.
Published: 16 February 2006
BMC Molecular Biology 2006, 7:5 doi:10.1186/1471-2199-7-5
Received: 23 September 2005
Accepted: 16 February 2006
This article is available from: http://www.biomedcentral.com/1471-2199/7/5
© 2006 Nakahata et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Molecular Biology 2006, 7:5 http://www.biomedcentral.com/1471-2199/7/5
Page 2 of 11
(page number not for citation purposes)
Background
Circadian rhythms are endogenous self-sustained oscilla-
tions with approximately 24-hr rhythmicity that are man-
ifested in various physiological and metabolic processes
[1,2] In mammals the circadian orchestration of these
processes is governed by pacemaker cells located within
the suprachiasmatic nuclei (SCN) of the hypothalamus. It
has also revealed that in mammals circadian oscillators
exist not only in the SCN but also in peripheral tissues,
and even in immortalized cells [3-5]. Because the perio-
dicity of the circadian clock only approximates that of the
environment, circadian clocks have to be adjusted to 24-
h/day period by environmental time cues [6]. Circadian
clocks are primarily synchronized with environmental
time by the daylight cycle as an input signal to the SCN
through the direct and indirect neural projections from
retinal ganglion cells [6,7], however, other non-photic
cues can also synchronize circadian clocks to 24-h/day
[2].
The molecular mechanism of the circadian oscillator as a
transcriptional-translational feedback loop has been
unraveled by genetic analysis in Drosophila and mammals
[8,9]. These molecular mechanisms based on the tran-
scriptional-translational regulation are conserved among
many species, including Arabidopsis,  Neurospora,  Dro-
sophila, zebrafish, and mammals [9-11]. In mammals,
principally two basic helix-loop-helix-PAS transcriptional
factors, CLOCK and BMAL1, regulate gene expression by
interacting with a promoter element termed E-box
[12,13]. Target genes of these transcriptional factors
include several repressor proteins, including PER1, PER2,
PER3, CRY1, and CRY2, which function to inhibit the
activity of CLOCK/BMAL1 complex by entering into the
nucleus [14,15], thereby generating a circadian oscillation
of their own transcription.
One of the molecular features of circadian clocks is rhyth-
mic fluctuation of clock gene mRNA amounts. In situ
hybridization and RNase protection assay are conven-
tional techniques used to detect expression profiles of the
clock and clock-controlled genes (for example, [4,16,17]).
Quantitative real-time RT-PCR has recently become a pop-
ular method to investigate mRNA expression profiles (for
example, [5,18]). The bioluminescent firefly luciferase
protein has proven to be a useful reporter protein for
monitoring the dynamics of gene activity in living cells
[19]. Luminescence from luciferase expressed in trans-
genic plants, Drosophila, zebrafish and mammals has been
used to monitor real-time dynamic change in gene tran-
scription within the living organism [19-22]. Since this
system is applied to transiently transfected cell cultures
with clock gene promoters driving firefly luciferase gene
expression [5,23], luciferase real-time monitoring system
using photomultiplier tubes has become a powerful tool
to investigate circadian clock mechanism, in particular to
identify the critical elements for producing the circadian
rhythmicity [24-26].
As described above, it has been thought that circadian
clocks in peripheral tissues are regulated by the SCN via
the secretion of hormones and/or the sympathetic/para-
sympathetic innervations from the SCN to peripheral tis-
sues [27]. Recently, some potential "entrainment factors"
have been reported [28-32], however, the mechanisms
how the central SCN pacemaker clock orchestrates the
peripheral clocks remains unclear. Here, we report system-
atic screening of various molecules in attempt to find
entrainment factors by using our in vitro real-time oscilla-
tion monitoring system (IV-ROMS). In this study, we
report eight novel candidates, including 15-deoxy-∆12,14-
prostaglandin J2 (15d-PGJ2), of entrainment factors for
circadian clocks.
Results and discussion
Establishment of IV-ROMS using mPer2-luc/Rat1 cell lines
The photomultiplier tube detector system can detect bio-
luminescence of luciferase protein and can measure it
every 15 min using a turntable (see Additional file 1). This
system is maintained in an incubator at 5% CO2 and
35°C. We first established mPer2-luc/Rat1 fibroblast cell
lines that stably express luciferase gene driven by mPer2
promoter. Per2 is considered to be one of the core mole-
cule for molecular clocks since gene-knockout analysis
revealed that mPer2 mutants display a shorted circadian
period followed by a loss of circadian rhythmicity in con-
stant darkness [33]. After stimulation with high concen-
tration of serum for 1 h, rhythmicity of luciferase activity
was monitored for duration of at least 2 or 3 days (Fig.
1A). In contrast to no oscillation in control (by DMSO
treatment), rhythmic activity of luciferase was observed.
Rhythmic phase of mPer2-luc/Rat1 cell lines was pheno-
typically the same as that in transiently transfected cells
with mPer2-luc construct and was antiphase compared to
transient transfected cells with hBmal1-luc construct [5].
These cell lines showed no abnormalities in their cell
growth and morphology. In summary, these cell lines
established here are suitable for the screening assay
designed to identify entrainment factors for circadian
clocks.
Screening of peptide and bioactive lipid libraries for 
circadian entrainment factors
The results of screening are shown in Figure 1B and Addi-
tional file 2 by using Peptide library (BAP96S, assayscript,
Osaka, Japan) and Bioactive lipid library (Version 3, BIO-
MOL, PA, USA). Out of 299 compounds screened, 12
demonstrated the rhythmic expression of luciferase.
Among them, four compounds (endothelin-1, all-trans
retinoic acid, 9-cis retinoic acid, and 13-cis retinoic acid)BMC Molecular Biology 2006, 7:5 http://www.biomedcentral.com/1471-2199/7/5
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Screening of entrainment factors by using IV-ROMS Figure 1
Screening of entrainment factors by using IV-ROMS. mPer2-luc/Rat1 cells were monitored the luciferase intensity for 
duration of 3 days using IV-ROMS. Figure 1A shows luciferase activity after 1 h treatment with 50% serum (positive control, 
left panel) or DMSO (negative control, right panel). Figure 1B shows luciferase activity after 1 h treatment with 1 or 10 µM of 
each of the 12 possible circadian entrainment factors. A representative result was chosen out of three independent experi-
ments. Abscissa presents "day", ordinate "relative luciferase intensity", respectively. The first peak was set to 1.BMC Molecular Biology 2006, 7:5 http://www.biomedcentral.com/1471-2199/7/5
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have already been reported as resetting factors in vivo or in
vitro [30,34]. By this assay, we newly identified eight can-
didates for circadian entrainment factors; prostaglandin J2
(PGJ2), ∆12-PGJ2, 15-deoxy-∆12,14-PGJ2 (15d-PGJ2), enan-
tio-PAF C16, 1-acyl-PAF, 6-formylindolo [3,2-B] carba-
zole, palmitoyl dopamine, and arachidonoyl dopamine.
These two libraries contain five known entrainment fac-
tors and we could identify all of them, except prostaglan-
din E2 [32], as an entrainment factor by this assay system
(see Additional file 2), indicating that this assay system is
reliable and suitable for screening of entrainment factors.
We could not identify prostaglandin E2 because prostag-
landin E2  receptor EP1, which is responsible for the
entrainment of circadian clocks, was not expressed in Rat1
cells, but was expressed in NIH3T3 cells that Tsuchiya et
al used [32] (see Additional file 3).
15d-PGJ2 triggers the rhythmic expression of endogenous 
clock genes in NIH3T3 cells
Among the eight novel candidates for entrainment factors,
we focused on 15d-PGJ2, because cells stimulated by 15d-
PGJ2 displayed the most robust effects on rhythmicity.
15d-PGJ2  has recently received increasing attention
because it functions as a potential regulator of diverse
processes including cell growth, proliferation, differentia-
tion, and inflammation [35]. In addition, 15d-PGJ2 is the
dehydration end product of PGD2. Interestingly, PGD2
has been recognized as the most potent endogenous
sleep-promoting substance [36]. Furthermore, the PGD2
concentration in rat cerebrospinal fluid shows a circadian
shift coupled to the sleep-wake cycle [37]. To confirm
whether 15d-PGJ2 is an authentic endogenous entrain-
ment factor, we examined the expression profiles of clock
genes in NIH3T3 fibroblast cells stimulated by 15d-PGJ2.
Per2  and  Bmal1  expression patterns were examined by
quantitative real-time RT-PCR at 4-h intervals for duration
of 56 h and rhythmic expressions were observed when
treated for 1 h with 15d-PGJ2 and with high concentration
serum, but not when treated with DMSO as a control (Fig.
2). Moreover, phases of Per2 and Bmal1 mRNA expression
triggered by 15d-PGJ2  treatment were antiphasic with
respect to each other, which is consistent with those trig-
gered by serum and with previously reported expression
profiles [5,38]. Taken together, these results demonstrate
that 15d-PGJ2 can act as an in vitro entrainment factor for
circadian clocks. PGD2  and other prostaglandins and
prostanoids examined in this study showed no rhythmic
fluctuation of luciferase activity (data not shown). The
facts that 15d-PGJ2's precursor PGD2 has been recognized
as the most potent endogenous sleep-promoting sub-
stance and that the PGD2 concentration in rat cerebrospi-
nal fluid shows a circadian change coupled to the sleep-
Endogenous clock gene expression profiles stimulated by 15d-PGJ2 Figure 2
Endogenous clock gene expression profiles stimulated by 15d-PGJ2. NIT3T3 cells were stimulated by 50% serum 
(positive control; left column), DMSO (negative control; right column), or 10 µM 15d-PGJ2 (middle panel) for 1 h. Total RNAs 
were isolated at each time point. Quantitative real-time RT-PCR was performed using mPer2 (upper panels), mBmal1 (bottom 
panels), and 18S rRNA primers. Abscissa presents "hour", ordinate "mRNA amount", respectively. mRNA amount at time 0 
was set to 1. The relative levels of each mRNA were normalized to the corresponding 18S rRNA levels.BMC Molecular Biology 2006, 7:5 http://www.biomedcentral.com/1471-2199/7/5
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wake cycle, have led to the hypothesis that 15d-PGJ2 may
act as an endogenous circadian entrainment factor in vivo.
It would be interesting to see the effects of 15d-PGJ2 in
vivo. However, it should be noted that the endogenous
concentration of 15d-PGJ2 is extremely low [39], com-
pared with the one used for the in vitro screening.
15d-PGJ2 up-regulates Cry1, Cry2, and Rorα mRNA 
expressions
To examine which clock genes are induced by 15d-PGJ2
treatment, we systematically quantified the expression
levels of the canonical clock genes. After the isolation of
total RNA at 1-h intervals from NIH3T3 cells stimulated
by 15d-PGJ2, quantitative real-time RT-PCR was per-
formed using primers for Per1, Per2, Per3, Bmal1, Npas2,
Cry1, Cry2, Dec1, Dec2, E4bp4, Dbp, and Rorα by using
low-density arrays. Unexpectedly, stimulation with 15d-
PGJ2 did not affect a transient Per1 and Per2 mRNA accu-
mulation (Fig. 3), although both Per genes are known to
be transiently accumulated by the various stimuli of
entrainment [40]. On the other hand, we for the first time
found that 15d-PGJ2 induced accumulation of Cry1 and
Cry2 transcripts, as well as Rorα mRNA (Fig. 3), which is
consistent with a previous report [41].
Entrainment triggered by 15d-PGJ2 is independent of 
PPAR-γ signaling pathway
We next sought to identify entrainment signaling path-
ways triggered by 15d-PGJ2. Since 15d-PGJ2 has been
known to be a natural ligand of the peroxisome prolifera-
15d-PGJ2 up-regulates Cry1, Cry2, and Rorα mRNA expression Figure 3
15d-PGJ2 up-regulates Cry1, Cry2, and Rorα mRNA expression. NIH3T3 cells were stimulated by 10 µM 15d-PGJ2 
(solid line) or DMSO (dotted line) for 1 h. Total RNAs were isolated at each time point. Quantitative real-time RT-PCR was 
performed using mCry1, mCry2, mRorα, mPer1, mPer2, mBmal1, and 18S rRNA primers. Abscissa presents "hour", ordinate 
"mRNA amount", respectively. Each mRNA amount at time point 0 was set to 1. Data are shown as the mean ± SE from three 
to five independent experiments. The relative levels of each mRNA were normalized to the corresponding 18S rRNA levels. *p 
< 0.05, **p < 0.01 compared with relative control (Student's t-test).BMC Molecular Biology 2006, 7:5 http://www.biomedcentral.com/1471-2199/7/5
Page 6 of 11
(page number not for citation purposes)
Rhythmic clock gene expression triggered by 15d-PGJ2 is independent of PPAR-γ-, MAPK-, JNK- and p38MAPK-signaling path- way Figure 4
Rhythmic clock gene expression triggered by 15d-PGJ2 is independent of PPAR-γ-, MAPK-, JNK- and 
p38MAPK-signaling pathway. After 1 h pretreatment of DMSO (15d; upper left panel), 10 µM GW9662 (GW+15d; upper 
right panel), 10 µM U0126 (U+15d; middle left panel), 20 µM SP600125 (SP+15d; middle right panel), or 30 µM SB203580 
(SB+15d; bottom left panel), NIH3T3 cells were stimulated by 10 µM 15d-PGJ2 for 1 h. As a negative control, NIH3T3 cells 
were pretreated by DMSO and stimulated by DMSO for 1 h (DMSO; bottom right panel). Total RNAs were isolated at each 
time point. Quantitative real-time RT-PCR was performed using mPer2 (solid line), mBmal1 (dotted line), and 18S rRNA prim-
ers. Abscissa presents "hour", ordinate "mRNA amount", respectively. The maximum mRNA amount was set to 1. The relative 
levels of each mRNA were normalized to the corresponding 18S rRNA levels.BMC Molecular Biology 2006, 7:5 http://www.biomedcentral.com/1471-2199/7/5
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Schema of the entrainment mechanism by 15d-PGJ2 Figure 5
Schema of the entrainment mechanism by 15d-PGJ2. 15d-PGJ2 up-regulates transcription of Crys and Rorα (Fig. 5Bi). 
The translated RORα activates Bmal1 transcription, and translated BMAL1 then binds to CLOCK and their heterodimers acti-
vate Per/Cry and Rev-erb transcriptions via E/E' box (Fig. 5Bii). Translated PER/CRY and REV-ERB inhibit Per/Cry/Rev-erb and 
Bmal1 transcription, respectively (Fig. 5Biii). The inhibition of Rev-erb transcription reduces Bmal1 transcription (Fig. 5Biv). The 
reduced Per/Cry transcription and relatively increased RORα activity (by inhibition of REV-ERB) again up-regulate Bmal1 tran-
scription (Fig. 5Biv -> 5Bii).BMC Molecular Biology 2006, 7:5 http://www.biomedcentral.com/1471-2199/7/5
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tor-activated receptor-γ (PPAR-γ) [42], we assessed
whether the clock gene expression triggered by 15d-PGJ2
is dependent on the PPAR-γ-mediated signaling pathway.
NIH3T3 cells pretreated with DMSO or with a specific
irreversible PPAR-γ antagonist GW9662 [43] were then
stimulated with 15d-PGJ2, and harvested at every 6 h for
duration of 54 h. Quantitative real-time RT-PCR using
primers for Per2 and Bmal1 showed no different expres-
sion patterns between GW9662 and DMSO pretreated
cells (Fig. 4). The same concentration (10 µM) of 15d-
PGJ2 induced GADD45 and catalase mRNA, which are
induced via PPAR-γ, in the same NIH3T3 cells, however,
no stimulation of both mRNAs was seen in these cells pre-
treated with 10 µM GW9662 (see Additional file 4), indi-
cating that these cells express PPAR-γ, that PPAR-γ was
involved in our observation, and that the amount of
GW9662 we used was enough for the system to work.
These results suggest that the circadian entrainment trig-
gered by 15d-PGJ2 is independent of the PPAR-γ signaling
pathway. We further confirmed that other PPAR-γ ligands,
Ciglitazone [44] and hexadecyl azelaoyl phosphatidly-
choline (azPC) [45], did not lead to the circadian expres-
sion of the clock genes (see Additional file 5).
We then explored which signaling pathways are involved
in 15d-PGJ2-induced rhythmic clock gene expression.
Recently, administration of 15d-PGJ2 was shown to acti-
vate ERK and JNK signaling pathways [42,46]. The known
entrainment factors are thought to mainly act by activat-
ing ERK signaling pathway [47]. We thus examined
whether these two MAPK signaling pathways can be
linked with 15d-PGJ2-induced cyclic gene expression.
Surprisingly, pretreatment of a specific JNK inhibitor
SP600125 [48] and of a specific MEK inhibitor U0126
[49], both showed no effect on the entrainment of circa-
dian clocks (Fig. 4). Although results of MAPK/ERK to
entrainment in the different systems have been inconsist-
ent [50], these results suggest that there exists an
unknown entrainment pathway, independent of the ERK-
mediated signaling pathway. Meanwhile, another path-
way, the p38 MAPK signaling pathway was recently
shown to be associated with circadian clocks by modulat-
ing their period lengths [51]. SB203580, a specific p38
inhibitor [52], slightly delayed the phase of Per2 rhythms
but did not affect circadian expression of both Per2 and
Bmal1 (Fig. 4), indicating that p38 MAPK signaling path-
way is involved in modulation of period length, but not
in the induction of clock gene expression by 15d-PGJ2.
The interpretation of this study on the transcription-trans-
lation feedback loops of clock genes are summarized in
Figure 5A. As shown in Figure 3, 15d-PGJ2 up-regulates
transcription of Crys and Rorα (Fig. 5Bi). The translated
RORα activates Bmal1 transcription [24,53,54], and trans-
lated BMAL1 binds to CLOCK forming a heterodimer
which activates Per/Cry and Rev-erb transcriptions via E/E'
elements (Fig. 5Bii; [12,13]). Translated PER/CRY and
REV-ERB inhibit transcription of Per/Cry/Rev-erb  and
Bmal1 genes, respectively (Fig. 5Biii). The inhibition of
Rev-erb  transcription also reduces Bmal1  transcription
(Fig. 5Biv; [55]). The reduced Per/Cry transcription and
relatively increased RORα activity (by inhibition of REV-
ERB) again up-regulate Bmal1 transcription and result in a
completion of the "loop" (Fig. 5Biv -> 5Bii).
In vitro real-time oscillation monitoring system (IV-ROMS)
IV-ROMS can be applied to identify molecules which are
involved in other mechanisms pertaining to circadian
clock system; transcriptional-translational feedback loops
of circadian mechanism and input signaling pathway
mechanism, for example, by using RNAi, inhibitor, and
other libraries. We can also apply this system to other
research fields. Further modification and development of
this system will be needed in order to be applied for more
systematic and high-throughput screenings.
Conclusion
Here we present the in vitro real-time oscillation monitor-
ing system (IV-ROMS). Indeed, we newly found eight can-
didates out of 299 compounds as circadian entrainment
factors (Fig. 1 and Additional file 2). We further con-
firmed that one of the candidates, 15d-PGJ2, triggers the
rhythmic expression of endogenous circadian clocks by
inducing Crys and Rorα, but not Pers, in NIH3T3 cells (Fig.
2), indicating that this assay system is a powerful and use-
ful tool for the initial screening procedure. This system
can also be applied not only to find new intracellular mol-
ecules involved in circadian clocks; new transcription fac-
tors, new signaling and degradation pathways, but also to




Rat1 and NIH3T3 fibroblast cells were grown at 37°C and
5% CO2. Rat1 and NIH3T3 cells were grown in Dulbecco's
Modified Eagle Medium (1.0 g/L glucose) with L-Gln and
sodium pyruvate (DMEM, Nacalai tesque, Kyoto, Japan)
supplemented with 5 and 10% fetal bovine serum (FBS),
respectively, and antibiotics.
Establishment of mPer2-luciferase-stably-expressing Rat1 
cell line
A bacterial artificial chromosome (BAC) clone
(pBeloBac11 24484) containing the complete genomic
sequence of the mouse Per2 (mPer2) gene was purchased
from BACPAC Resource Center at Children's Hospital
Oakland Research Institute. The mPer2 promoter region
was isolated and cloned in the pGL3 Basic vector
(Promega). The mPer2 region spans from -2811 to +110BMC Molecular Biology 2006, 7:5 http://www.biomedcentral.com/1471-2199/7/5
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(+1 indicates the putative transcriptional start site). Rat1
cells were cotransfected with linearized mPer2 promoter/
pGL3 and pcDNA3, which contains neomycin resistant
gene. Transfection was carried out by using Polyfect Trans-
fection Reagent (QIAGEN) according to the manufac-
ture's instructions. The cells were cultured in 10% FBS/
DMEM containing 500 µg/ml geneticin (SIGMA) for 1 to
2 weeks. Cells were then individually isolated, and 24
clones were established as mPer2-luc/Rat1 cells. After
screening for the luciferase activity by using IV-ROMS, we
established two independent clones with clear rhythmic
activity.
Real-time luciferase activity monitoring in living cells
mPer2-luc/Rat1 cells were seeded in a 35 mm-dish at den-
sity of 2 × 105 cells and incubated for 2 days. The medium
was then exchanged for serum-free medium supple-
mented with a compound to be screened. Compound was
diluted to a final concentration of 1 µM for peptide and 1
or 10 µM for bioactive lipid, respectively. One hour later
the medium was replaced with 1% FBS/DMEM supple-
mented with 0.1 mM luciferin/10 mM HEPES (pH 7.2).
Light emission was measured and integrated for 1 min at
intervals of 15 min with a photomultiplier tube (Hama-
matsu Photonics, Hamamatsu, Japan). Data were ana-
lyzed by LM2400 software (Hamamatsu Photonics).
Real-time quantitative RT-PCR
TaqMan® Low Density Array (Applied Biosystems), which
contained  mPer1,  mPer2,  mPer3,  mArntl  (mBmal1),
mNpas2,  mCry1,  mCry2,  mBhlhb2  (mDec1),  mBhlhb3
(mDec2), mDbp, and mNfil3 (mE4bp4) as clock genes and
18S rRNA as an internal control, was examined by using
an ABI PRISM 7900HT Sequence Detection System
(Applied Biosystems) as described previously [56]. For
one port of the TaqMan Low Density Array, 100 ng cDNA
template was mixed with 50 µl of 2 × TaqMan Universal
PCR Master Mix (Applied Biosystems) and filled up to 100
µl with distilled water. The reaction was first incubated at
50°C for 2 min, then at 95°C for 10 min, followed by 40
cycles of 95°C for 15 sec and 60°C for 1 min.
Each real-time quantitative RT-PCR was performed by
using an ABI PRISM 7900HT Sequence Detection System
as described previously [5]. Briefly, DNase-treated total
RNA (1 µg) was reverse-transcribed by using a random
hexamer primer and Superscript reverse transcriptase
(Invitrogen). The cDNA equivalent to 50 ng total RNA was
PCR-amplified. The PCR primers and TaqMan probes (5'
FAM and 3' TAMRA) used are as follows:
mPer2 FW: CGC CTA GAA TCC CTC CTG AGA,
mPer2 RV: CCA CCG GCC TGT AGG ATC T,
mPer2  TaqMan probe: AGG CTG TGG ATG AAA GGG
CGG TC,
mBmal1 FW: GCA GTG CCA CTG ACT ACC AAG A,
mBmal1 RV: TCC TGG ACA TTG CAT TGC AT,
mBmal1 TaqMan probe: ATC AAG AAT GCA AGG GAG
GCC CAC A,
18S rRNA FW: CGC CGC TAG AGG TGA AAT TC,
18S rRNA RV: CGA ACC TCC GAC TTT CGT TCT,
18S rRNA TaqMan probe: CCG GCG CAA GAC GGA CCA
GA.
The PCR primers for mCry1,  mCry2, and mRorα  were
described previously [5,24]. Values are reported as mean
± SE. Statistical differences were determined by a Student's
t test. Statistical significance is displayed as * (p < 0.05) or
** (p < 0.01).
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SCN, suprachiasmatic nuclei; IV-ROMS, in vitro real-time
oscillation monitoring system; 15d-PGJ2, 15-deoxy-∆12,14-
prostaglandin J2; PPAR-γ, peroxisome proliferators-acti-
vated receptor-γ; RT-PCR, reverse transcription-polymer-
ase chain reaction; DMEM; Dulbecco's modified eagle
medium; FBS, Fetal bovine serum
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Compound libraries used in this assay. Peptide library (BAP96S, assay-
script, Osaka, Japan) and Bioactive lipid library (Version 3, BIOMOL, 
Plymouth Meeting, PA, USA) were used in this screening assay. Numbers 
in parentheses indicate the number of known entrainment factors.




EP1 mRNA is expressed in NIH3T3 cells, but not in Rat1 cells. Total 
RNAs were isolated from NIH3T3 and Rat1 cells and semi-quantitative 
real-time RT-PCR was performed using prostaglandin E2 receptor EP1 
and G3PDH primers. G3PDH mRNA was used as an internal control. 
For EP1 and G3PDH, the cDNA equivalent to 50 ng and 0.5 ng of total 
RNA respectively, were PCR-amplified by 30 cycles each.




Pretreatment of PPAR-γ antagonist, GW9662, repressed 15d-PGJ2-
induced PPAR-γ-mediated gene expressions. The effect of GW9662 on 
PPARγ-mediated GADD45 (A) and catalase (B) mRNA expressions was 
evaluated by using a quantitative real-time PCR. 1 h GW9662 (GW: +) 
or DMSO (GW: -) pretreated-NH3T3 cells were stimulated by 15d-PGJ2 
(15d: +) or DMSO (15d: -). mRNA amounts after 1 h stimulation 
by15d-PGJ2 or DMSO were measured. The mRNA amount of GW: -, 
15d: - condition was set to 1. The relative levels of each mRNA were nor-
malized to the corresponding 18S rRNA levels. Data are shown as the 
mean ± SE from three independent experiments. *p < 0.05, **p < 0.01 
compared with the condition 'GW: -, 15d: +'. (Student's t-test).




15d-PGJ2-induced entrainment mechanism for circadian clocks is 
independent of PPAR-γ-signaling pathway. After 1 h pretreatment with 
(middle right panel) or without (middle left panel) PPAR-γ antagonist, 
GW96662, mPer2-luc/Rat1 cells were stimulated by 15d-PGJ2 for 1 h 
and the luciferase intensity was monitored by using IV-ROMS. mPer2-
luc/Rat1 cells stimulated for 1 h by PPAR-γ agonists, azPC (bottom left 
panel) or ciglitazone (bottom right panel) were monitored by using IV-
ROMS. A representative result was chosen out of at least three independ-
ent experiments. Abscissa presents "day", ordinate "relative luciferase 
intensity", respectively.
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